174 related articles for article (PubMed ID: 6603392)
1. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.
Karbach U; Ewe K; Bodenstein H
Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392
[TBL] [Abstract][Full Text] [Related]
2. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.
Karbach U; Ewe K; Dehos H
Dig Dis Sci; 1985 Mar; 30(3):229-35. PubMed ID: 2857632
[TBL] [Abstract][Full Text] [Related]
4. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
Karbach U; Singe CC; Ewe K
Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
[TBL] [Abstract][Full Text] [Related]
5. Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy?
Haeney MR; Fields J; Carter RA; Thompson RA; Asquith P
Lancet; 1979 Dec; 2(8153):1161-2. PubMed ID: 91891
[TBL] [Abstract][Full Text] [Related]
6. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
Hundegger K; Stufler M; Karbach U
Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
[TBL] [Abstract][Full Text] [Related]
7. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
[TBL] [Abstract][Full Text] [Related]
8. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance.
Karbach U; Ewe K
Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983
[TBL] [Abstract][Full Text] [Related]
9. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
Thomas DW; Sinatra FR; Merritt RJ
J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis.
Kapel N; Meillet D; Favennec L; Magne D; Raichvarg D; Gobert JG
Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):197-202. PubMed ID: 1525248
[TBL] [Abstract][Full Text] [Related]
11. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
Fischbach W; Becker W; Mössner J; Koch W; Reiners C
Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
[TBL] [Abstract][Full Text] [Related]
12. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease.
Grill BB; Hillemeier AC; Gryboski JD
J Pediatr Gastroenterol Nutr; 1984; 3(1):56-61. PubMed ID: 6607330
[TBL] [Abstract][Full Text] [Related]
13. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss.
Quigley EM; Ross IN; Haeney MR; Holbrook IB; Marsh MN
J Clin Pathol; 1987 Jan; 40(1):61-6. PubMed ID: 3493263
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)].
Florent C; L'Hirondel C; Desmazures C; Giraudeaux V; Bernier JJ
Gastroenterol Clin Biol; 1981 Feb; 5(2):193-7. PubMed ID: 6970700
[No Abstract] [Full Text] [Related]
16. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
[TBL] [Abstract][Full Text] [Related]
17. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy.
Florent C; L'Hirondel C; Desmazures C; Aymes C; Bernier JJ
Gastroenterology; 1981 Oct; 81(4):777-80. PubMed ID: 6973500
[TBL] [Abstract][Full Text] [Related]
18. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.
Bernier JJ; Florent C; Desmazures C; Aymes C; L'Hirondel C
Lancet; 1978 Oct; 2(8093):763-4. PubMed ID: 80688
[TBL] [Abstract][Full Text] [Related]
20. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
Boege F; Fischbach W
Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
